SAM
Shell Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,784
| Closed | -$53K | – | 1259 |
|
|
2023
Q3 | $53K | Sell |
4,784
-75
| -2% | -$831 | ﹤0.01% | 1181 |
|
|
2023
Q2 | $104K | Sell |
4,859
-28
| -0.6% | -$599 | ﹤0.01% | 1111 |
|
|
2023
Q1 | $198K | Sell |
4,887
-17
| -0.3% | -$689 | 0.01% | 926 |
|
|
2022
Q4 | $228K | Sell |
4,904
-1,035
| -17% | -$48.1K | 0.01% | 903 |
|
|
2022
Q3 | $308K | Sell |
5,939
-1,547
| -21% | -$80.2K | 0.01% | 815 |
|
|
2022
Q2 | $354K | Buy |
7,486
+17
| +0.2% | +$804 | 0.01% | 894 |
|
|
2022
Q1 | $532K | Sell |
7,469
-1,104
| -13% | -$78.6K | 0.01% | 786 |
|
|
2021
Q4 | $641K | Buy |
8,573
+29
| +0.3% | +$2.17K | 0.01% | 782 |
|
|
2021
Q3 | $485K | Sell |
8,544
-370
| -4% | -$21K | 0.01% | 881 |
|
|
2021
Q2 | $392K | Buy |
8,914
+480
| +6% | +$21.1K | 0.01% | 1017 |
|
|
2021
Q1 | $416K | Buy |
8,434
+4,368
| +107% | +$215K | 0.01% | 924 |
|
|
2020
Q4 | $171K | Hold |
4,066
| – | – | ﹤0.01% | 1162 |
|
|
2020
Q3 | $186K | Buy |
4,066
+825
| +25% | +$37.7K | ﹤0.01% | 1060 |
|
|
2020
Q2 | $163K | Buy |
3,241
+9
| +0.3% | +$453 | ﹤0.01% | 1064 |
|
|
2020
Q1 | $166K | Sell |
3,232
-50
| -2% | -$2.57K | ﹤0.01% | 1047 |
|
|
2019
Q4 | $203K | Sell |
3,282
-123
| -4% | -$7.61K | ﹤0.01% | 1129 |
|
|
2019
Q3 | $205K | Sell |
3,405
-29
| -0.8% | -$1.75K | ﹤0.01% | 1127 |
|
|
2019
Q2 | $290K | Sell |
3,434
-2,631
| -43% | -$222K | 0.01% | 1060 |
|
|
2019
Q1 | $579K | Hold |
6,065
| – | – | 0.01% | 844 |
|
|
2018
Q4 | $430K | Sell |
6,065
-500
| -8% | -$35.4K | 0.01% | 888 |
|
|
2018
Q3 | $561K | Buy |
+6,565
| New | +$561K | 0.01% | 921 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1090 |
|
|
2017
Q1 | – | Sell |
-15,946
| Closed | -$534K | – | 1094 |
|
|
2016
Q4 | $534K | Buy |
+15,946
| New | +$534K | 0.01% | 858 |
|